Members |
targetComponentId |
Lignocaine hydrochloride+adrenaline 2%/1:200000 sterile wrapped injection |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
Lignocaine hydrochloride+glucose 5%/7.5% injection |
Lidocaine hydrochloride 50 mg/mL solution for injection |
Lincomycin 300mg/mL injection |
Lincomycin only product in parenteral dose form |
linkomycinhydroklorid 300 mg/ml, injektionsvätska, lösning, ampull |
Lincomycin only product in parenteral dose form |
linezolid 100 mg/5 ml, granulat till oral suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Linezolid 100mg/5mL granules for oral suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Linezolid 100mg/5mL suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
linezolid 2 mg/ml, infusionsvätska, lösning, påse 300 ml |
Product containing precisely linezolid 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Liothyronine sodium preparation |
Product containing liothyronine (medicinal product) |
Lipoma of spinal column |
Lipoma of spinal cord |
liposarkom |
Liposarcoma |
liposomalt daunorubicin 2 mg/ml, injektionsvätska, emulsion |
Product containing only daunorubicin liposome in parenteral dose form (medicinal product form) |
liposomal doxorubicinhydroklorid 2 mg/ml, infusionskoncentrat, flaska 10 ml |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
liposomal doxorubicinhydroklorid 2 mg/ml, infusionskoncentrat, flaska 25 ml |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Liquid paraffin [eye] |
Product containing mineral oil (medicinal product) |
Liquid paraffin [laxative] |
Product containing mineral oil (medicinal product) |
liraglutid 6 mg/ml, injektionsvätska, lösning |
Product containing only liraglutide (medicinal product) |
lisinoprilallergi |
Non-allergic hypersensitivity to lisinopril |
Listeria murrayi |
Listeria grayi (organism) |
litiumkarbonat 300 mg, tablett med modifierad frisättning |
Product containing only lithium carbonate in oral dose form (medicinal product form) |
litiumkarbonat 300 mg, depåtablett |
Product containing only lithium carbonate in oral dose form (medicinal product form) |
livedoid vaskulit i nedre extremitet orsakad av varicer på ben |
Livedoid vasculopathy of lower limb due to varicose veins of lower limb (disorder) |
fixering med dynamiska drag |
Dynamic splinting |
leverabscess förutom leverabscess orsakad av amöba |
Abscess of liver |
Liver derivative complex 25.5mg injection |
Liver extract only product |
leverderivatkomplex 25,5 mg/ml + injektionsvätska, lösning, ampull |
Liver extract only product |
Living on the street |
Homeless |
Living organism |
Organism (organism) |
Living organism category not applicable |
Organism (organism) |
Living organism not assigned code in SNOMED |
Organism (organism) |
Living organism not assigned to a scientific category |
Organism (organism) |
Living organism not identified |
No living organism identified (finding) |
Lloyd's syndrome |
Autoimmune polyendocrinopathy |
hummer, livsmedel |
Lobster (substance) |
Local convulsion |
Partial seizure |
Local cyst of bone |
Bone cyst |
Localization-related epilepsy |
Partial seizure |
lokaliserad vuxenparodontit |
Localized chronic periodontitis |
Locked twins obstructing labor |
Interlocked twins |
lomefloxacin 0,3 %, ögondroppar |
Lomefloxacin 3 mg/mL eye solution |
långt atoniskt anfall |
Atonic seizure (disorder) |
Long-acting thyroid stimulator |
Thyroid stimulating immunoglobulins |
Loperamide 2mg oral lyophilisate tablet |
Loperamide hydrochloride 2 mg oral tablet |
loperamidhydroklorid 1 mg/5 ml, oral sirap |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
loperamidhydroklorid 1 mg/5 ml, sockerfri sirap |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
loperamidhydroklorid 2 mg, munsönderfallande tablett |
Loperamide hydrochloride 2 mg oral tablet |
Loperamide hydrochloride+simethicone |
Product containing loperamide and simeticone (medicinal product) |
Lophortyx gambelii |
Callipepla gambelii (organism) |
lorakarbef 100 mg/5 ml, oral suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Loracarbef 100mg/5mL suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
lorakarbef 200 mg/5 ml, oral suspension |
Loracarbef 40 mg/mL oral suspension |
Loracarbef 200mg/5mL suspension |
Loracarbef 40 mg/mL oral suspension |
Loracarbef, anhydrous 100mg/5mL powder |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Loracarbef, anhydrous 200mg/5 mL powder |
Loracarbef 40 mg/mL oral suspension |
loratadin 10 mg/10 ml, sirap |
Loratadine 1 mg/mL oral solution |
loratadin + pseudoefedrinsulfat 5 mg/120 mg, tablett med modifierad frisättning |
Loratadine and pseudoephedrine only product in oral dose form |
loratadin 5 mg + pseudoefedrinsulfat 120 mg, depåtablett |
Loratadine and pseudoephedrine only product in oral dose form |
lordos vid höftsjukdom |
Lordosis deformity of spine due to disorder of hip region |
lordos vid skelettdysplasi |
Lordosis deformity of spine due to congenital skeletal dysplasia |
lovastatin 10 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
lovastatin 10 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
lovastatin 20 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
lovastatin 20 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
lovastatin 40 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
lovastatin 40 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
lovastatin 60 mg, tablett med modifierad frisättning |
Product containing only lovastatin in oral dose form (medicinal product form) |
lovastatin 60 mg, depåtablett |
Product containing only lovastatin in oral dose form (medicinal product form) |
lågt cervikalt kejsarsnitt |
Lower uterine segment caesarean section |
Low cervical cesarean section |
Lower uterine segment caesarean section |
Low pressure hydrocephalus |
Normal pressure hydrocephalus |
Lower uterine segment cesarean delivery NEC |
Lower uterine segment caesarean section |
Lucilia sericata |
Phaenicia sericata |
lumbal somatisk dysfunktion |
Somatic dysfunction of lumbar region (finding) |
Lumbar spine DXA scan |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
Lumbar spine DXA scan |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
Lumbar spine DXA scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
Lumbar spine DXA scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
Lumbar spine dual energy X-ray absorptiometry scan (procedure) |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
T-poäng vid DXA-skanning av ländrygg |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
Z-poäng vid DXA-skanning av ländrygg |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
LE-cell |
Lupus erythematosus cell |
Luteinizing hormone releasing factor |
Gonadotropin releasing factor |
Luteinizing hormone releasing factor preparation |
Product containing gonadotropin releasing factor (product) |
Lutropin alfa 75iu injection (pdr for recon)+solvent |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
lutropin alfa 75 IE, pulver för beredning av injektionsvätska, + spädningsvätska |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Luy's nucleus (body structure) |
Structure of subthalamic nucleus of Luy (body structure) |
lymfadenoid struma |
Hashimoto thyroiditis |
Lymphadenopathy-associated virus, type II (LAV-II) |
Human immunodeficiency virus type 2 |
lymfangiom |
Benign lymphangioma |
Lymphocystis disease virus group |
Genus Lymphocystivirus (organism) |
lymfatisk leukemi, kategori |
Lymphoid leukaemia |
Lymphoma morphology |
Malignant lymphoma |
lymfoproliferativ sjukdom |
Lymphoproliferation of uncertain behavior (morphologic abnormality) |
Lymphosarcoma cell leukemia |
Lymphoid leukaemia |
Lymphosarcoma cell leukemia |
Lymphoid leukaemia |
Lymphosarcoma of extranodal AND/OR solid organ site |
Non-Hodgkin's lymphoma (clinical) |
Lymphosarcoma of intra-abdominal lymph nodes |
Mixed cell type lymphosarcoma of intra-abdominal lymph nodes |
Lymphosarcoma of intrapelvic lymph nodes |
Non-Hodgkin's lymphoma (clinical) |
Lymphosarcoma of intrathoracic lymph nodes |
Mixed cell type lymphosarcoma of intrathoracic lymph nodes (disorder) |